Sabitlenmiş Tweet
Ances Mulles
23.7K posts

Ances Mulles retweetledi

“A Change Is Gonna Come” to Treatment of Lupus Nephritis: A Review - American Journal of Kidney Diseases.
Well summarised all trials in LUPUS NEPHRITIS! 💯🔥👌🏻
#MedTwitter #ajkd
#NephTwitter
ajkd.org/article/S0272-…

English

@ancesmulles Natural history post training. Don't worry, it will pick up in due time.
English
Ances Mulles retweetledi

A 60 y/o woman with long-standing SLE treated with prednisone, HCQ, and mycophenolate presented with reddish purple infarctions around the nail folds of multiple fingers (A) that were asymptomatic and resolved after several weeks
Clinical images in ACROR
doi.org/10.1002/acr2.7…

English
Ances Mulles retweetledi

Review of IL-1 family cytokines in inflammation and immunity - including, IL-1, IL-18, IL-33, IL-36, IL-37, IL-38, IL-1Ra, etc. Full read -- Good Reference!! buff.ly/s1nTJNd

English
Ances Mulles retweetledi

A high ANA titer (≥1:640) in individuals without an autoimmune disease was found to be strongly associated with liver-related disorders, including nonalcoholic and alcoholic liver disease
Arthritis Care & Research
doi.org/10.1002/acr.25…

English
Ances Mulles retweetledi

BREAKING NEWS
The 2025 #NobelPrize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi “for their discoveries concerning peripheral immune tolerance.”

English
Ances Mulles retweetledi
Ances Mulles retweetledi

The UP Philippine General Hospital has expressed its solidarity with the rest of the UP community and the country, in calling for good governance, integrity in public service, and climate-resilient solutions to floods: web.facebook.com/upsystem/posts…

English
Ances Mulles retweetledi
Ances Mulles retweetledi

🌍At #APLAR2025, Prof @LupusReference highlighted our new review with @G_O_Daniel on social determinants of health in Autoimmunity Reviews.
Thank you both for your dedication to this key topic!
Read how inequities can directly impact #lupus outcomes
sciencedirect.com/science/articl…
Mark Lawrence Lagac@marklagacmd
He believes that there are plenty of inequalities in SLE tx. New txs don’t necessarily mean it will be available, in some countries, affordable. Targeted tx — still far from it. But a personalized + digital treatment is a good equation for SLE tx. #APLAR25 #APLAR2025 #SLE
English
Ances Mulles retweetledi

The ILD-RISC score has been developed and validated as the first multi-parametric, consensus-based, data-driven algorithm to predict the presence of systemic sclerosis-associated interstitial lung disease (SSc-ILD) on high-resolution computed tomography (HRCT). In addition to its high sensitivity (85.6%) in identifying patients who should undergo HRCT at baseline, this screening tool (including FVC%, DLCO/SB%, digital ulcers ever, age and SSc autoantibodies) performed well during follow-up to decide when to repeat HRCTs in baseline ILD negative patients.
In fact, it may avoid more than 50% of unnecessary CTs during follow-up, when a low score is calculated.
*Bruni C, Tofani L, Fretheim H et al. A screening tool to detect interstitial lung disease in systemic sclerosis: the ILD-RISC Score. Rheumatology (Oxford), 2025.
🔗doi.org/10.1093/rheuma…

English




